Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
News
10/9/2024
IQVIA Releases the 2024 White Paper on Development Trends in China's O...
10/9/2024
SMEI: Chinese Terminal Drug Market Grew 5.2% in 2023
10/9/2024
US Venture Capital Opens Funding Opportunities for China Biotech Firms
10/9/2024
Bayer Launches Life Sciences Incubator in Shanghai
10/9/2024
NMPA Announces Package Insert Revision of Mezlocillin Sodium Containin...
10/8/2024
China Grants Conditional Approval to Biogen's ALS Therapy Qalsody
10/8/2024
CStone to Report Positive Preclinical Data of Anticancer Candidate CS2...
10/8/2024
Aadi Bio Wins Arbitration, Rejecting Multimillion-Dollar Claim from Ch...
10/8/2024
AstraZeneca Expanding R&D pipeline in China
10/8/2024
CSPC Announces Regulatory Milestones in China and the U.S.
10/8/2024
CDE Issues the List of Reference Formulations for GQCE Studies (83rd B...
10/8/2024
BeiGene Launches Tevimbra in US, Enters Competitive PD-1 Inhibitor Mar...
10/8/2024
Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...
10/8/2024
Wuhan YZY Biopharma and CT Tianqing Enter Exclusive License Agreement ...
10/8/2024
China to Establish a Unified Mapping Database for Traceability Codes, ...
10/8/2024
BeiGene Initiates Phase I Trial for FGFR2b ADC BG-C137 in Advanced Sol...
10/8/2024
Zephyrm Bioscience Files for IPO on HKSE with CICC as Sponsor
10/8/2024
Genor Biopharma to Merge with Eddingpharm in Strategic Reverse Takeove...
10/8/2024
Innovent and Ask Pharm Enter Strategic Deal for Limertinib
10/8/2024
AstraZeneca gains rights to CSPC's lipid-lowering therapy in deal wort...
10/8/2024
MediLink and Amgen Enter Global Clinical Trial Deal on YL201 Combinat...
10/3/2024
Recent Executive Moves
10/3/2024
Domestic Pharma Companies Saw Rapid Growth in Outlicensing Deals in 20...
10/3/2024
WuXi Considers Asset Sales Amid BIOSECURE Scrutiny: FT
10/2/2024
Publication Announcement on the Inclusion of Marstacimab as Pilot Proj...
10/2/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
10/2/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Clinica...
10/2/2024
CDE Solicits Comments on the Proposed BE Study Guidelines for Five Gen...
10/2/2024
CDE Solicits Comments on the Proposed Technical Guidelines for Writing...
10/2/2024
China Issues New Regulation on Network Data Security Management
Page:
17
/
42
Total number of articles:
1234
:
[First]
[<<]
[15]
[16]
[17]
[18]
[19]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit